Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes: Balancing Benefits and Risks

SOGC has updated their previous 2003 guideline on antenatal corticosteroid therapy after synthesizing the evidence that has accumulated over the last several years.1 This commentary provides a brief overview of the new guideline's recommendations (Table), highlights key issues, contrasts the current recommendations with those in the 2003 guideline and those in the guidelines of other national obstetric institutions, and suggests a few areas for future research.